InsidersTradesSigma
CanSino Biologics Inc.: insider trades · Hong Kong · HKEX
HKEX:cansino-biologics-inc-h-sharesHK·HKEXMcap 7.0Bn€Healthcare
Discover the full directors' dealings record of CanSino Biologics Inc., a listed equity based in Hong Kong. Shares are listed on HK HK, under the authority of HKEX. Operating in the Healthcare sector, CanSino Biologics Inc. has published 3 reports. Market capitalisation: €7bn. The latest transaction was reported on 30 March 2026 (Purchase). Among the most active insiders: Chao Shou Bai. The full history is openly available.
3
Insider Decl.
0
Thresholds
·
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
28.42 €
Analyst consensus
5 analysts42.75 €Target 48.69 €(+71%)53.38 €
Income statement
Revenue1.06 Bn€
Gross profit799.3 M€75% margin
Net income27.9 M€-0.1% margin
Valuation
PER (trailing)218.6x
PER (forward)21.9x
P/Book1.2x
Beta1.16
Balance sheet & cash
Market cap7.02 Bn€
Total debt1.29 Bn€
Free Cash Flow−166.0 M€
Debt / Equity24%
Profitability & ownership
ROE-0.0%
ROA-0.8%
% insiders26.9%
% institutions15.1%
Last declaration on 30 March 2026
Declarations3 total
Executives●Purchase6HKEX
162,500 shares
ShareXHKG
HKEX:DA20260330E00022·
Ideal exit: 23 Jun 2026 (T+270)
Executives●Purchase6HKEX
371,300 shares
ShareXHKG
HKEX:DA20260330E00025·
Ideal exit: 23 Jun 2026 (T+270)
3 of 3 declarations